Name | Number of supported studies | Average coverage | |
---|---|---|---|
brush cell | 4 studies | 65% ± 18% |
Insufficient scRNA-seq data for expression of AVIL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 380.96 | 180 / 180 | 95% | 5.05 | 410 / 430 |
breast | 98% | 327.17 | 452 / 459 | 95% | 3.26 | 1061 / 1118 |
pancreas | 98% | 303.93 | 320 / 328 | 96% | 5.05 | 170 / 178 |
thymus | 100% | 831.06 | 653 / 653 | 93% | 3.70 | 561 / 605 |
lung | 98% | 482.33 | 566 / 578 | 92% | 3.97 | 1059 / 1155 |
brain | 90% | 386.19 | 2383 / 2642 | 99% | 10.85 | 700 / 705 |
esophagus | 96% | 256.89 | 1388 / 1445 | 92% | 3.12 | 169 / 183 |
adrenal gland | 99% | 568.24 | 255 / 258 | 90% | 2.98 | 206 / 230 |
intestine | 100% | 467.70 | 966 / 966 | 87% | 2.99 | 460 / 527 |
uterus | 100% | 303.45 | 170 / 170 | 85% | 2.60 | 388 / 459 |
bladder | 100% | 350.00 | 21 / 21 | 84% | 3.19 | 423 / 504 |
stomach | 96% | 273.97 | 345 / 359 | 87% | 4.51 | 248 / 286 |
prostate | 100% | 457.15 | 245 / 245 | 79% | 1.56 | 398 / 502 |
kidney | 100% | 500.16 | 89 / 89 | 79% | 2.12 | 714 / 901 |
skin | 95% | 237.00 | 1727 / 1809 | 67% | 1.71 | 318 / 472 |
liver | 90% | 284.25 | 203 / 226 | 61% | 3.35 | 246 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.70 | 1 / 1 |
muscle | 100% | 707.42 | 801 / 803 | 0% | 0 | 0 / 0 |
spleen | 99% | 478.12 | 239 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 289.14 | 1305 / 1335 | 0% | 0 | 0 / 0 |
adipose | 97% | 328.99 | 1163 / 1204 | 0% | 0 | 0 / 0 |
heart | 94% | 228.84 | 811 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 1.67 | 30 / 45 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.78 | 17 / 29 |
peripheral blood | 56% | 425.75 | 520 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 44% | 0.79 | 35 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060271 | Biological process | cilium assembly |
GO_0051016 | Biological process | barbed-end actin filament capping |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0010592 | Biological process | positive regulation of lamellipodium assembly |
GO_1900480 | Biological process | regulation of diacylglycerol biosynthetic process |
GO_0008154 | Biological process | actin polymerization or depolymerization |
GO_0051014 | Biological process | actin filament severing |
GO_0007015 | Biological process | actin filament organization |
GO_0007399 | Biological process | nervous system development |
GO_0043005 | Cellular component | neuron projection |
GO_0005884 | Cellular component | actin filament |
GO_0005925 | Cellular component | focal adhesion |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0030424 | Cellular component | axon |
GO_0030027 | Cellular component | lamellipodium |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0051015 | Molecular function | actin filament binding |
GO_0071933 | Molecular function | Arp2/3 complex binding |
GO_0003779 | Molecular function | actin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | AVIL |
Protein name | Advillin Advillin (p92) |
Synonyms | |
Description | FUNCTION: Ca(2+)-regulated actin-binding protein which plays an important role in actin bundling . May have a unique function in the morphogenesis of neuronal cells which form ganglia. Required for SREC1-mediated regulation of neurite-like outgrowth. Plays a role in regenerative sensory axon outgrowth and remodeling processes after peripheral injury in neonates. Involved in the formation of long fine actin-containing filopodia-like structures in fibroblast. Plays a role in ciliogenesis. In podocytes, controls lamellipodia formation through the regulation of EGF-induced diacylglycerol generation by PLCE1 and ARP2/3 complex assembly . . |
Accessions | F8VVU1 ENST00000549851.5 F8VNY0 ENST00000549994.2 [O75366-1] O75366 ENST00000257861.7 [O75366-1] ENST00000549994 |